Simultaneously, treatment with PP2 significantly reduced nuclear PKM2 levels, suppressing the transcription of its downstream target genes (such as GLUT1, LDHA, and MYC) and markedly weakening tumor cells’ glycolytic capacity and proliferative ability [30]. This evidence concerns the gene LDHA and neoplasm.